JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M608618200 on January 4, 2007

J. Biol. Chem., Vol. 282, Issue 10, 7576-7581, March 9, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/10/7576    most recent
M608618200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onoguchi, K.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onoguchi, K.
Right arrow Articles by Fujita, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Viral Infections Activate Types I and III Interferon Genes through a Common Mechanism*

Kazuhide Onoguchi{ddagger}§, Mitsutoshi Yoneyama{ddagger}§, Azumi Takemura{ddagger}, Shizuo Akira||, Tadatsugu Taniguchi**, Hideo Namiki, and Takashi Fujita{ddagger}§1

From the {ddagger}Laboratory of Molecular Genetics, Institute for Virus Research and §Graduate School of Biostudies, Kyoto University, Kyoto 606-8507, Japan, Department of Biology, School of Education, Waseda University, Tokyo 169-0051, Japan, ||Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan, and **Department of Immunology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan

Viral infections trigger innate immune responses, including the production of type I interferons (IFN-{alpha} and -beta) and other proinflammatory cytokines. Novel antiviral cytokines IFN-{lambda}1, IFN-{lambda}2, and IFN-{lambda}3 are classified as type III IFNs and have evolved independently of type I IFNs. Type III IFN genes are regulated at the level of transcription and induced by viral infection. Although the regulatory mechanism of type I IFNs is well elucidated, the expression mechanism of IFN-{lambda}s is not well understood. Here, we analyzed the mechanism by which IFN-{lambda} gene expression is induced by viral infections. Loss- and gain-of-function experiments revealed the involvement of RIG-I (retinoic acid-inducible gene I), IPS-1, TBK1, and interferon regulatory factor-3, key regulators of the virus-induced activation of type I IFN genes. Consistent with this, a search for the cis-regulatory element of the human ifn{lambda}1 revealed a cluster of interferon regulatory factor-binding sites and a NF-{kappa}B-binding site. Functional analysis demonstrated that all of these sites are essential for gene activation by the virus. These results strongly suggest that types I and III IFN genes are regulated by a common mechanism.


Received for publication, September 6, 2006 , and in revised form, January 2, 2007.

* This work is supported by the Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science, and Technology of Japan, Uehara Memorial Foundation, and Nippon Boehringer Ingelheim. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Laboratory of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto 606-8507, Japan. Tel.: 81-75-751-4031; Fax: 81-75-751-4031; E-mail: tfujita{at}virus.kyoto-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
N. Ank, M. B. Iversen, C. Bartholdy, P. Staeheli, R. Hartmann, U. B. Jensen, F. Dagnaes-Hansen, A. R. Thomsen, Z. Chen, H. Haugen, et al.
An Important Role for Type III Interferon (IFN-{lambda}/IL-28) in TLR-Induced Antiviral Activity
J. Immunol., February 15, 2008; 180(4): 2474 - 2485.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. E. Randall and S. Goodbourn
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
J. Gen. Virol., January 1, 2008; 89(1): 1 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Koyama, K. J. Ishii, H. Kumar, T. Tanimoto, C. Coban, S. Uematsu, T. Kawai, and S. Akira
Differential Role of TLR- and RLR-Signaling in the Immune Responses to Influenza A Virus Infection and Vaccination
J. Immunol., October 1, 2007; 179(7): 4711 - 4720.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. I. Osterlund, T. E. Pietila, V. Veckman, S. V. Kotenko, and I. Julkunen
IFN Regulatory Factor Family Members Differentially Regulate the Expression of Type III IFN (IFN-{lambda}) Genes
J. Immunol., September 15, 2007; 179(6): 3434 - 3442.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
M. J. Carter
A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza
J. Med. Microbiol., July 1, 2007; 56(7): 875 - 883.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.